Donald Trump didn’t kill the TPP. His opposition was only the final blow which came at the end of more than six years of criticism in the US, Australia and other countries by public health, environment, church, union and other community groups, writes AFTINET Convener Pat Ranald for Fairfax media.
22 November 2016: There were a lot of different media reports flying around about the future of the TPP during the APEC meeting in Lima over the weekend. Here’s our explainer.
14 November 2016: Over the weekend, the US administration confirmed that they would not push the TPP through the current lame duck Congress: effectively abandoning the deal.
While Trump's election may have dealt the final blow, it's been people like you and organisations like ours which have campaigned since 2010 against the TPP's corporate agenda.
November 12, 2016: New analysis of leaked TiSA documents finds the deal would concentrate more power for multinational corporations, put a stranglehold on vital government regulation, undo the limited progress which has been made on regulating banks and finance conglomerates, and lead to an "Uberisation" of millions of workers' jobs.
11 November 2016: Even if the TPP never goes into effect, its damage will be felt worldwide - in the form of the election of President Donald Trump, writes Lori Wallach, director of Public Citizen’s Global Trade Watch.
November 10, 2016: The shock election of Donald Trump as the next US President does not necessarily mean the TPP will never be ratified, as some are predicting. In fact, the TPP could still pass the current lame duck Congress held before Mr Trump is sworn into office on January 20 next year.
6 November 2016: Peter Martin writes in Fairfax Media, that the RCEP is "another massive deal you've never heard of” which has ISDS on the agenda, despite the strong opposition ISDS has created to the TPP, and predicts the TPP’s demise . He cites a statement from hundreds of US law professors opposing ISDS because it would allow foreign investors to bypass "the basic procedures of the US justice system” .
MEDIA RELEASE, November 7 2016: “The Australian government should reject the push from US Republican Congress members to increase biologic medicine monopolies by seven years, even more than the extra three years which has already been agreed in the TPP text,” Dr Patricia Ranald, Convener of the Australian Fair Trade and Investment Network said today.